4.6 Article

Targeting Class IA PI3K Isoforms Selectively Impairs Cell Growth, Survival, and Migration in Glioblastoma

Related references

Note: Only part of the references are listed.
Article Oncology

Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor

Sauveur-Michel Maira et al.

MOLECULAR CANCER THERAPEUTICS (2012)

Review Oncology

Genomic determinants of P13K pathway inhibitor response in cancer

Britta Weigelt et al.

FRONTIERS IN ONCOLOGY (2012)

Article Biochemistry & Molecular Biology

A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

Stephen Jamieson et al.

BIOCHEMICAL JOURNAL (2011)

Review Oncology

PI3Kinase signaling in glioblastoma

M. M. Lino et al.

JOURNAL OF NEURO-ONCOLOGY (2011)

Review Oncology

Mechanisms of mTOR inhibitor resistance in cancer therapy

Jennifer S. Carew et al.

TARGETED ONCOLOGY (2011)

Article Pathology

Structural Typing of Systemic Amyloidoses by Luminescent-Conjugated Polymer Spectroscopy

K. Peter R. Nilsson et al.

AMERICAN JOURNAL OF PATHOLOGY (2010)

Article Oncology

PI(3)King Apart PTEN's Role in Cancer

Siyuan Zhang et al.

CLINICAL CANCER RESEARCH (2010)

Article Clinical Neurology

The clinicopathologic values of the molecules associated with the main pathogenesis of the glioblastoma

Bomi Kim et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)

Article Oncology

Akt2 and Akt3 play a pivotal role in malignant gliomas

Hideo Mure et al.

NEURO-ONCOLOGY (2010)

Article Oncology

mTOR signaling in glioblastoma: lessons learned from bench to bedside

David Akhavan et al.

NEURO-ONCOLOGY (2010)

Review Medicine, General & Internal

Malignant gliomas in adults

Patrick Y. Wen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Multidisciplinary Sciences

PTEN-deficient cancers depend on PIK3CB

Susan Wee et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

Novel role for insulin as an autocrine growth factor for malignant brain tumour cells

Alexandre Arcaro et al.

BIOCHEMICAL JOURNAL (2007)

Review Clinical Neurology

The 2007 WHO classification of tumours of the central nervous system

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2007)

Article Biochemistry & Molecular Biology

Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling

Claire Chaussade et al.

BIOCHEMICAL JOURNAL (2007)

Article Multidisciplinary Sciences

Rare cancer-specific mutations in PIK3CA show gain of function

Marco Gymnopoulos et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Oncology

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas

Marjut Puputti et al.

MOLECULAR CANCER RESEARCH (2006)

Article Oncology

PIK3CA gene mutations in pediatric and adult glioblastoma multiforme

Gary L. Gallia et al.

MOLECULAR CANCER RESEARCH (2006)

Letter Clinical Neurology

Mutations of the PIK3CA gene are rare in human glioblastoma

W Mueller et al.

ACTA NEUROPATHOLOGICA (2005)

Article Clinical Neurology

PIK3CA mutations in glioblastoma multiforme

C Hartmann et al.

ACTA NEUROPATHOLOGICA (2005)

Article Biochemistry & Molecular Biology

PI 3-kinase p110β:: a new target for antithrombotic therapy

SP Jackson et al.

NATURE MEDICINE (2005)

Article Multidisciplinary Sciences

Accessing key steps of human tumor progression in vivo by using an avian embryo model

M Hagedorn et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

High frequency of mutations of the PIK3CA gene in human cancers

Y Samuels et al.

SCIENCE (2004)

Article Clinical Neurology

Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas

M Mizoguchi et al.

BRAIN PATHOLOGY (2004)

Review Medicine, General & Internal

Medical progress: Brain tumors

LM DeAngelis

NEW ENGLAND JOURNAL OF MEDICINE (2001)